Lazard Asset Management LLC Invests $19.48 Million in ICU Medical, Incorporated (NASDAQ:ICUI)

Lazard Asset Management LLC bought a new stake in ICU Medical, Incorporated (NASDAQ:ICUI) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 81,400 shares of the medical instruments supplier’s stock, valued at approximately $19,481,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Advisory Services Network LLC boosted its position in ICU Medical by 475.0% in the fourth quarter. Advisory Services Network LLC now owns 115 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 95 shares during the last quarter. Berman Capital Advisors LLC purchased a new position in shares of ICU Medical in the 4th quarter worth about $33,000. CX Institutional purchased a new position in shares of ICU Medical in the 1st quarter worth about $34,000. Rockefeller Capital Management L.P. purchased a new stake in ICU Medical during the 1st quarter valued at about $35,000. Finally, Financial Gravity Companies Inc. purchased a new stake in ICU Medical during the 4th quarter valued at about $45,000. Hedge funds and other institutional investors own 90.05% of the company’s stock.

Shares of NASDAQ:ICUI opened at $238.18 on Friday. ICU Medical, Incorporated has a 52-week low of $210.94 and a 52-week high of $321.70. The company has a market capitalization of $4.93 billion, a PE ratio of 30.89 and a beta of 0.72.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings data on Thursday, May 9th. The medical instruments supplier reported $2.35 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.96 by $0.39. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The company had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. During the same quarter last year, the company earned $2.26 EPS. The firm’s revenue for the quarter was down 11.0% on a year-over-year basis. On average, research analysts expect that ICU Medical, Incorporated will post 8.55 earnings per share for the current fiscal year.

In other ICU Medical news, Director Robert S. Swinney sold 229 shares of the stock in a transaction on Friday, April 12th. The stock was sold at an average price of $231.43, for a total transaction of $52,997.47. Following the sale, the director now directly owns 18,076 shares in the company, valued at approximately $4,183,328.68. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Kevin J. Mcgrody sold 7,344 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $231.68, for a total value of $1,701,457.92. Following the sale, the insider now owns 7,574 shares in the company, valued at $1,754,744.32. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,921 shares of company stock valued at $2,971,607. 11.40% of the stock is owned by corporate insiders.

A number of research analysts have commented on the company. Zacks Investment Research lowered ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. BidaskClub raised ICU Medical from a “sell” rating to a “hold” rating in a research report on Friday, May 24th. TheStreet raised ICU Medical from a “c+” rating to a “b” rating in a research report on Friday, May 10th. Finally, Raymond James decreased their target price on ICU Medical from $315.00 to $300.00 and set a “strong-buy” rating for the company in a research report on Friday, March 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $281.00.

TRADEMARK VIOLATION WARNING: This story was reported by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.com-unik.info/2019/06/14/lazard-asset-management-llc-invests-19-48-million-in-icu-medical-incorporated-nasdaqicui.html.

About ICU Medical

ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.

See Also: What is a capital gain?

Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Incorporated (NASDAQ:ICUI).

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit